Mergers and acquisitions are expected to rebound in 2024 after M&A activity fell to its lowest level in 10 years globally in 2023, according to Reuters.
Dealmaking last year was weighed down by high interest rates, economic uncertainty and a regulatory…
The Centers for Medicare and Medicaid Services has announced a new model to test approaches for addressing behavioral and physical health, as well as social needs, for people with Medicaid and Medicare.
The model will launch in the fall 2024 and is an…
Every two years RevSpring, a company focused on billing and engagement, takes the pulse of the patient in its Voice of the Patient Survey to find out what’s changed and what’s remained the same in the care experience.
Mastercard has announced a medical claims payment partnership in India using its virtual card technology.
Mastercard has teamed with financial institutions and Remedinet, a cloud-based health tech platform that connects hospitals, insurers and third-…
Gene therapy has made all the difference for young patients at Children’s National Hospital in Washington, D.C., according to Eric Manuel Balmir, PharmD, vice president of clinical ancillary services and chief pharmacy officer.
The Centers for Medicare and Medicaid Services is releasing data on the Acute Hospital Care at Home initiative through the Research and Data Assistance Center.
ResDAC collected data from November 27, 2020, through March 30, 2023. As required for partic…
Under a final rule released today, impacted payers will be required to send prior authorization decisions within 72 hours for urgent requests and seven calendar days for standard requests.
Over 20 million people have selected an Affordable Care Act health plan since the 2024 Marketplace Open Enrollment Period launched on November 1, according to the Department of Health and Human Services, calling this a record number of enrollments.
The Centers for Medicare and Medicaid Services has terminated two Centene Medicare Advantage plans, in Part C and D enforcement action taken December 27.
Walgreens Boots Alliance has agreed to pay $360 million to Humana to settle a lawsuit alleging the retail pharmacy overcharged for prescription drug reimbursements.